Global News

Treatment guidelines for virus highlight challenge of paying for expensive drugs in low-income countries.

 

Campaigners in India have been calling for access to cheap hepatitis C treatments.

The publication last week of the first treatment guidelines for hepatitis C virus (HCV), and the advent of drugs that can cure most infections of the virus, have left public-health researchers with a touch of déjà vu.

 

Three decades after wrestling to lower the cost of AIDS drugs (prices fell from about US$10,000 per patient per year in the 1990s to less than $100 in the mid-2000s), they are once again asking how expensive life-saving medicines can be made affordable for patients.

 

AttachmentSize
viral_load.jpg26.73 KB

Gaucher's disease is a rare human genetic condition caused by hereditary deficiency of that enzyme.

People with Gaucher's -- which can manifest itself with fatigue, bruising, anaemia, low blood platelets and an enlarged liver and spleen -- often are treated with drugs and bone marrow transplants but still face pain and often poor long-range health prospects.

Scientists in Brazil have genetically modified a goat to produce milk with an enzyme to treat a rare genetic disorder, O Estado de Sao Paulo newspaper reported Tuesday.

The goat, named "Gluca," is the first of its kind in South America. It has been genetically modified to produce the enzyme glucocerebrosidase.

CLF Intro movie

Financial Aid Offered by Trusts

Follow us on: